삼진제약
19,310KRWMarket close of 10/27 (Tue)
Up +0.78%+150KRWMarket close of 10/27 (Tue)
Preliminary value — replaced once official KRX data for the same date is publishedClose of 10/28 (Wed)19,240KRWDown -0.36%
Preliminary · replaced once official KRX data for the same date is published
- Open
- 19,210
- High
- 19,490
- Low
- 19,200
- Day range
- Day range low 19,200 high 19,490, open 19,210, close 19,310, previous close 19,160
- Volume
- 4×10K shares
- 704.62 million KRW 1.06× the 20-session average
Market close of 10/27 (Tue)
Where it sits in the 1-year range
30%30% of the way up from the lowest close in 1 year (252 sessions) · -21.8% from the high
Free · no sign-inSource from 2021-05-17
Points to check
- Earningsnot verifiedThe last four quarters are incomplete, so not verified
- Recent filingsnot verifiedOutside filing data coverage, so not verified
- Foreign & institutionalnot verifiedOutside investor-flow coverage, so not verified
The other 2 are within the usual range
- Daily move+0.78%usual range
- Trading value1.1×usual range
See the full check report
Filings in the last 2 years · 0
Material events are checked for the top 400 stocks only — this stock shows periodic reports only.
- 2023-04-10Annual report (2022.12)Amended
Same sector · 제약
Down -2.22%· 88 of 168 stocks up, preferred shares excluded · trading value 553.0B KRW
| Stock | 20D | Change | Trading value |
|---|---|---|---|
| 삼성바이오로직스 | Close over the last 20 sessions +0.6% | Down -5.37% | 124.5B KRW |
| 셀트리온 | Close over the last 20 sessions +6.3% | Down -0.74% | 82.4B KRW |
| 지투지바이오 | Close over the last 20 sessions +22.2% | Down -13.38% | 46.9B KRW |
| 한미약품 | Close over the last 20 sessions -32.6% | Down -0.57% | 25.5B KRW |
| 에스티팜 | Close over the last 20 sessions -11.9% | Down -9.15% | 21.4B KRW |
Schedule
- Next data 10/29 (Thu) after 08:50
Related news
Tables, financials, investor flows and filing history are in the Detailed view.
Investor flows, financials and valuation are provided for 369 stocks. These stocks account for about 82% of trading value, about 92% of market capitalisation. Coverage status →
For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.